130 related articles for article (PubMed ID: 8258990)
1. Induction of cytotoxic lymphocyte subsets against leukemia by stimulation with AML blasts.
Lotzová E; Savary CA
Med Oncol Tumor Pharmacother; 1993; 10(1-2):13-9. PubMed ID: 8258990
[TBL] [Abstract][Full Text] [Related]
2. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.
Weidmann E; Brieger J; Jahn B; Hoelzer D; Bergmann L; Mitrou PS
Ann Hematol; 1995 Mar; 70(3):153-8. PubMed ID: 7718644
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.
Orleans-Lindsay JK; Barber LD; Prentice HG; Lowdell MW
Clin Exp Immunol; 2001 Dec; 126(3):403-11. PubMed ID: 11737054
[TBL] [Abstract][Full Text] [Related]
4. Generation of MHC-nonrestricted and restricted oncolytic subsets from human bone marrow.
Fuchshuber PR; Lotzová E; Savary CA
Cell Immunol; 1992 Jan; 139(1):30-43. PubMed ID: 1728969
[TBL] [Abstract][Full Text] [Related]
5. Recent approaches to induction of cytotoxic lymphocytes against leukemia.
Lotzová E
Leukemia; 1993 Aug; 7 Suppl 2():S69-74. PubMed ID: 8361237
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
[TBL] [Abstract][Full Text] [Related]
7. Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients.
Siegler U; Meyer-Monard S; Jörger S; Stern M; Tichelli A; Gratwohl A; Wodnar-Filipowicz A; Kalberer CP
Cytotherapy; 2010 Oct; 12(6):750-63. PubMed ID: 20491532
[TBL] [Abstract][Full Text] [Related]
8. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
Bruserud O; Ulvestad E
J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
[TBL] [Abstract][Full Text] [Related]
9. Histamine and interleukin-2 in acute myelogenous leukemia.
Hellstrand K; Mellqvist UH; Wallhult E; Carneskog J; Kimby E; Celsing F; Brune M
Leuk Lymphoma; 1997 Nov; 27(5-6):429-38. PubMed ID: 9477124
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
[TBL] [Abstract][Full Text] [Related]
11. Resistance of some leukemic blasts to lysis by lymphokine activated killer (LAK) cells.
Panayotides P; Porwit A; Sjögren AM; Wasserman J; Reizenstein P
Eur J Haematol; 1988 Apr; 40(4):362-7. PubMed ID: 3259192
[TBL] [Abstract][Full Text] [Related]
12. Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies.
Bruserud O
Leukemia; 1999 Aug; 13(8):1175-87. PubMed ID: 10450745
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1997 Oct; 45(1):45-52. PubMed ID: 9353426
[TBL] [Abstract][Full Text] [Related]
14. Conjugate formation by leukemic blasts from acute myeloid leukemia with cytotoxic lymphocytes.
Palucka AK; Porwit A; Reizenstein P
Leuk Lymphoma; 1993 Nov; 11(5-6):427-33. PubMed ID: 7907248
[TBL] [Abstract][Full Text] [Related]
15. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
16. An overview of the potential strategies for NK cell-based immunotherapy for acute myeloid leukemia.
Sinha C; Cunningham LC
Pediatr Blood Cancer; 2016 Dec; 63(12):2078-2085. PubMed ID: 27535002
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.
Romee R; Rosario M; Berrien-Elliott MM; Wagner JA; Jewell BA; Schappe T; Leong JW; Abdel-Latif S; Schneider SE; Willey S; Neal CC; Yu L; Oh ST; Lee YS; Mulder A; Claas F; Cooper MA; Fehniger TA
Sci Transl Med; 2016 Sep; 8(357):357ra123. PubMed ID: 27655849
[TBL] [Abstract][Full Text] [Related]
18. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.
Siegler U; Kalberer CP; Nowbakht P; Sendelov S; Meyer-Monard S; Wodnar-Filipowicz A
Leukemia; 2005 Dec; 19(12):2215-22. PubMed ID: 16224486
[TBL] [Abstract][Full Text] [Related]
19. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
[TBL] [Abstract][Full Text] [Related]
20. Profiles of activation, differentiation-markers, or β-integrins on T cells contribute to predict T cells' antileukemic responses after stimulation with leukemia-derived dendritic cells.
Vogt V; Schick J; Ansprenger C; Braeu M; Kroell T; Kraemer D; Köhne CH; Hausmann A; Buhmann R; Tischer J; Schmetzer H
J Immunother; 2014; 37(6):331-47. PubMed ID: 24911794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
